Aiming to demonstrate the existence of autocrine release and subsequent stimulation of MM growth, Hov et al.[15] reported that either a selective c-MET inhibitor (PHA665752) or a neutralizing anti-HGF antibody reduced proliferation of the myeloma cell line ANBL-6 as well as primary MM cells. The gene discussed is MET; the disease is Miyoshi myopathy.